BCTXL
BriaCell Therapeutics Corp. Warrant expiring 2031stockNASDAQWarrant
At CloseNov 17, 2026 9:37:01 AM EST
0.81USD-14.737%(-0.14)78,676
BCTXL Financials
In Q4 FY 2026 (ended ), BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) reported net income of −$12.32M, operating cash flow of −$5.96M, and assets of $23.58M (filed ).
Loading financial flows…